Who Are the Core Customers in Avanos Company's Target Market?

Avanos target customers are chiefly hospitals and surgical centers where clinicians choose devices like COOLIEF Radiofrequency Treatment to reduce opioid use; these accounts generated an estimated $1.2 billion in medical device revenues industry-wide where Avanos participates in 2025 clinical channels.

Avanos customer segments include Group Purchasing Organizations and Integrated Delivery Networks that standardize purchases of Mic-Key enteral feeding tubes and wound care supplies; contracting through GPOs influences uptake across thousands of hospitals and long-term care facilities.

Avanos mainly serves institutions and businesses – hospitals, ASCs, home healthcare providers – while end users are patients; procurement managers and clinical buyers (physicians, respiratory therapists) jointly decide purchases to meet reimbursement and quality goals.

The most important segment by revenue and strategic reach is hospital/ASC accounts where clinician adoption of COOLIEF and procurement-led contracts for enteral feeding systems drive recurring consumable sales and device placements; targeting these customers supports higher recurring EBITDA contribution in 2025.

North America is the primary market for Avanos target customers; it generated about 78 percent of Avanos Medical total revenue in fiscal 2025 and concentrates hospital procurement managers and surgical centers purchasing Avanos devices. The ASC channel is the fastest-growing environment as procedures shift to outpatient settings, driving higher per-procedure volumes for clinicians using Avanos devices.

EMEA and Asia-Pacific are the notable secondary markets for Avanos core customers, especially for enteral feeding systems and digestive health products. Growth follows healthcare infrastructure investment, standardized enteral feeding protocols, and rising purchases by hospitals and health systems as well as distributors for Avanos medical devices.

Avanos appears strongest where recurring consumables and enteral feeding supplies supply steady demand – hospital respiratory care departments, ICU and critical care customers, and long-term care facilities contribute substantial recurring revenue. Home healthcare providers and value-based care organizations are growing sources of repeat purchases and long-tail revenue.

The enteral feeding segment sustained an organic growth rate of roughly 5 to 7 percent into early 2026, driven by an aging population and expansion of home-based long-term care facilities, which now represent a meaningful portion of Avanos recurring revenue. Expect increased demand from home healthcare providers and long-term care facilities purchasing Avanos supplies.

Avanos target customers expand as the company adds portable interventional pain tools (Diros Technology integration, 2025) that open ambulatory surgery centers and pain clinics; enteral feeding systems and Mic-Key consumables drive footprint in hospitals and home healthcare providers, increasing penetration among clinicians using Avanos devices and long-term care facilities.

High switching costs for Mic-Key feeding systems, recurring consumable purchases, and comprehensive clinical training programs lock Avanos core customers into workflows; hospital procurement managers and respiratory care departments face operational friction and reimbursement alignment that reduce churn.

Recurring revenue from disposables (enteral nutrition tubes, wound care dressings) plus renewals for clinical service contracts produce predictable demand; distributors for Avanos medical devices and home care patients using Avanos products drive depth – consumables represent the largest share of repeat purchases.

The razor-and-blade model – enteral feeding systems selling durable devices and recurring Mic-Key disposables – remains the single biggest growth lever in 2025/2026, supported by targeted acquisitions that broaden the Avanos target market and by positioning as a strategic supplier to consolidating hospitals and health systems.